SANTA BARBARA Hundreds of autism experts from around the world gathered at UC Santa Barbara today (Sept. 19) for the Sixth Annual International Pivotal Response Treatment (PRT) Autism and Asperger's Conference. Sponsored by UC Santa Barbara's Koegel Autism Center, the two-day conference at Corwin Pavilion features scholars, educators, health care professionals, parents and even grandparents discussing autism, Asperger's syndrome, and cutting-edge intervention and treatments strategies. According to Lynn Kern Koegel, clinical director of the Koegel Autism Center and the Broad Asperger Center, and one of two keynote speakers, the main focus of this year's conference is PRT and the associated techniques for treating every aspect of autism spectrum disorder from first words to socialization, to social conversation across all age levels, from infants to adults. The conference began with Robert Koegel, director of the Koegel Autism Center and the second keynote speaker, providing an overview of PRT. Developed at UC Santa Barbara, PRT is a protocol based on principles of positive motivation. Researchers have found that increasing children's participation in activities they enjoy can actually lessen the severity of autism spectrum disorder symptoms and open the door to more positive social interaction. Their work with infants was highlighted in the … Continue reading →

Dallas, TX (PRWEB) September 20, 2013 Stroke occurs when the blood supply to the brain is blocked or interrupted, either by blood clots or ruptured blood vessels, depriving the brain of oxygen and nutrients, ultimately leading to the death of brain cells. Stroke is a major cause of death, morbidity, and long-term disability. To forecast the incident and prevalent cases of stroke in the 6MM, Epidemiologists selected studies that used the WHO definition of stroke: rapidly developing clinical signs of focal disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin. This definition excludes cases of transient ischemic attacks (TIAs), which are neurological deficits lasting less than 24 hours. This report also provides the incident cases of AIS segmented by the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria subtypes and the proportion of recurrent cases of AIS out of the total cases of AIS (total cases of AIS = incident cases of first-ever AIS + recurrent cases of AIS) in these major markets. Complete report is available @ http://www.rnrmarketresearch.com/epicast-report-acute-ischemic-stroke-epidemiology-forecast-to-2022-market-report.html. Epidemiologists forecast that the incident cases of AIS in the 6MM will increase by 20.10% … Continue reading →

THE eighth annual Our Heroes Awards was a night where celebrities and VIPs gathered to pay tribute to inspirational individuals and unsung heroes who go the extra mile to help others. The night's moving moments at the Moat House Hotel, in Festival Park, Etruria, came courtesy of the nominees. An audience of 250 people heard stories of unconditional love, daily struggles, selflessness and determination that provide lessons for us all. The whole spectrum of emotions were experienced, from sadness to sheer joy at seeing such deserving people receive recognition. During the past eight years, The Our Heroes Awards, sponsored by The Aspire Group, has seen The Sentinel publish more than 1,000 heartwarming stories and prizes have been given out to more than 200 winners. Following a black-tie dinner, 29 awards were handed out during an Oscars-style ceremony hosted by Aspire Group chief executive Sinad Butters and Sentinel columnist and deputy editor Martin Tideswell. The Only Way Is Stoke (TOWIS) Print voucher EYEBROW WAX FOR ONLY 3 AND EYEBROW TINTING IS ONLY 5. BOOK NOW AND SET OFF YOUR GORGEOUS EYES AT THE ONLY WAY IS STOKE XX Contact: 01782 917864 Valid until: Tuesday, December 31 2013 The first award of … Continue reading →

Irvine, CA (PRWEB) September 20, 2013 Proove Biosciences, Inc., the leading personalized pain medicine laboratory, is excited to announce that they will be attending and exhibiting at the California Society of Interventional Pain Physicians 4th Annual Meeting this weekend at the Terranea Resort in Rancho Palos Verdes, California. The event will be held from September 20th to September 22nd. CASIPP is a growing advocacy society working for interventional pain management physicians and their staff within the state of California. The organizations mission is to promote the development and practice of safe, high quality, cost-effective interventional pain medicine techniques for the diagnosis and treatment of pain and related disorders, and ensure patient access to these interventions. We are proud to support Dr. Ray d'Amours, the President and Executive Director of CASIPP in this important conference, explains Proove CEO and founder, Brian Meshkin. Proove is a research-driven company committed to realizing the potential of personalized pain medicine. We are proud to stand with Dr. dAmours and his colleagues at the forefront of pain medicine genetics. We continue to be the only company to present clinical research on the genetics of pain medicine at scientific meetings throughout the year including, PAINWeek, the American … Continue reading →